![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, July 13, 2020 9:34:23 PM
Thank You, Dr Mark and CEO Cris...GLTA...
Hi TCM:
Yes, I can confirm we are working with Algernon on both the AGN120-2 and AGN120-3 trials.
Nancy
Nancy Stewart, Ph.D.
Senior Scientific Manager/gvicds
Clinical Development Solutions
4-1250 Waverley St. Winnipeg MB CANADA R3T 6C6
Email: nstewart-gvicds
-----Original Message-----
From: tc
Sent: July 13, 2020 7:09 PM
To: Nancy Stewart nstewart-gvicds
Subject: Clinical Trial for Ifenprodil
Hello Dr Stewart
I am a long time invertor in Algernon Pharma. I am using the link from the CC site. I have watched the CEO, Chris Monroe discuss working with GVI on the COVID / Ifenprodil Clinical Trial. Just want to confirm this, no inside info. I may post a positive reply with permission.
I would really like just a link to a public statement, if possible. IMO, it will be Great to have the assistance...
Thank You
TCM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM